Bioequivalence Study Between Tasimelteon Capsule Formulation and Liquid Suspension Formulation in Healthy Volunteers
Clinical trial NCT05572281 · COMPLETED
Trial details
- NCT number
- NCT05572281
- Sponsor
- Vanda Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-18
- Primary completion
- 2022-06-15
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.